ImmunoPrecise Antibodies (IPA)
(Delayed Data from NSDQ)
$0.67 USD
+0.03 (4.69%)
Updated Sep 13, 2024 03:59 PM ET
After-Market: $0.65 -0.02 (-2.99%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth C Momentum D VGM
Industry / Sector Report
Industry : Medical Info Systems
Zacks Industry Rank
Top 29% (72 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.50 | 1.79 | 9.99 |
Current Quarter Estimate | -0.09 | -0.74 | 61.00 |
Year Ago Quarter Estimate | -0.11 | -0.21 | 54.84 |
Next Quarter Estimate | -0.04 | 0.15 | 63.00 |
Next Year Estimate | -0.14 | 1.25 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 67.95 | 20.90 | 15.67 |
Next Year | 44.00 | 24.10 | 11.34 |
Last 5 Years | NA | -10.70 | 8.10 |
Next 5 Years | NA | 18.20 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | 25.51 |
Price/Book (MRQ) | 0.72 | 1.35 |
Price/Cash Flow (MRFY) | NA | 6.69 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -110.66% | -48.54% |
Return on Equity (TTM) | -57.05% | -43.61% |
Debt to Equity (MRQ) | NA | 2.90 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.